[ Price : $8.95]
FDA warns Innocore Sales & Marketing in Woodstock, Ontario, Canada, about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA names acting Office of New Drugs (OND) director Mary Tran Thanh-Hai as the new OND director, replacing previous head Peter Ste...[ Price : $8.95]
Three Hyman, Phelps & McNamara attorneys notice that FDA has provided a 30-day response time instead of the usual 15 days for two ...[ Price : $8.95]
FDA posts a seven-item Form FDA-483 after inspecting Dr. Reddys Mirfield, West Yorkshire, UK, active pharmaceutical ingredient man...[ Price : $8.95]
Intellia Therapeutics pauses two Phase 3 trials of nex-z, a CRISPR-based therapy for transthyretin amyloidosis with cardiomyopathy...[ Price : $8.95]
A Senate Committee demands answers from HHS on what they describe as serious national security and public health risks tied to Ame...[ Price : $8.95]
BridgeBio reports positive Phase 3 data for BBP-418 in limb-girdle muscular dystrophy patients as it plans an NDA filing in second...[ Price : $8.95]
FDA releases a draft guidance outlining recommendations for medical device manufacturers on the type of Quality Management System ...